{"id":"NCT01947855","sponsor":"Boehringer Ingelheim","briefTitle":"Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus","officialTitle":"A Randomised, Double-blind, Placebo-controlled, Parallel Group, 4-week Study to Evaluate the Efficacy of Empagliflozin (10 mg and 25 mg Administered Orally Once Daily) in Postprandial Glucose and 24-hour Glucose Variability in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2013-09-23","resultsPosted":"2014-12-24","lastUpdate":"2014-12-24"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Empagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Empagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Empagliflozin low dose","type":"EXPERIMENTAL"},{"label":"Empagliflozin high dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of empagliflozin administered orally once daily in postprandial glucose and 24-hour glycaemic variability compared to placebo given for 4 weeks as mono-therapy in Japanese patients with type 2 diabetes mellitus with insufficient glycaemic control on no antidiabetic treatment.","primaryOutcome":{"measure":"Change in Area Under the Concentration-time Curve (AUC1-4h) for Postprandial Plasma Glucose From Baseline After 28 Days of Treatment","timeFrame":"1h, 1.5h, 2h, 2.5, 3h, 3.5h and 4h after drug administration at day -1 (baseline), and 1h, 1.5h, 2h, 2.5, 3h, 3.5h and 4h after drug administration at day 28","effectByArm":[{"arm":"Placebo","deltaMin":-18.07,"sd":13.89},{"arm":"Empagliflozin 10 mg","deltaMin":-103.56,"sd":14.24},{"arm":"Empagliflozin 25 mg","deltaMin":-122.94,"sd":14.35}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":2,"countries":["Japan"]},"refs":{"pmids":["35472672","31444706","25633683"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Nasopharyngitis","Anal inflammation","Rash pruritic","Pollakiuria","Bartholinitis"]}}